STOCK TITAN

Biote Stock Price, News & Analysis

BTMD Nasdaq

Welcome to our dedicated page for Biote news (Ticker: BTMD), a resource for investors and traders seeking the latest updates and insights on Biote stock.

Biote Corp. (NASDAQ: BTMD) is a solutions provider in preventive health care that concentrates on personalized hormone optimization, therapeutic wellness and healthy aging. Through its network of Biote-certified medical providers, the company reports on developments that affect its hormone optimization programs, provider network and practice-building activities.

The Biote news feed typically features quarterly and annual financial results, where the company discusses trends in procedure revenue, dietary supplement revenue, product and service revenue, gross profit margin and non-GAAP metrics such as Adjusted EBITDA and Adjusted EBITDA margin. These updates often explain how factors like the vertical integration of a 503B manufacturing facility, organizational restructuring and changes in commercial strategy influence financial performance.

Investors and observers can also find corporate announcements in Biote’s news, including organizational restructuring of commercial teams, strategic priorities focused on new providers and top-tier clinics, and changes in the Board of Directors. The company has highlighted actions such as realigning its commercial organization, modifying sales roles and compensation, and electing new board members.

Another recurring theme in Biote’s news is capital allocation and share activity, including share repurchase programs and open market share purchases by directors and executives. These disclosures provide context on how management views the company’s long-term outlook and capital structure.

For readers tracking BTMD, the news page offers a centralized view of Biote’s earnings releases, guidance updates, restructuring announcements and governance changes. Regularly reviewing this information can help users understand how Biote’s preventive health care focus, provider network and financial strategy evolve over time.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.91%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.76%
Tags
conferences earnings
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.13%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.36%
Tags
buybacks
-
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.61%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.61%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.75%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.8%
Tags
conferences earnings

FAQ

What is the current stock price of Biote (BTMD)?

The current stock price of Biote (BTMD) is $1.36 as of March 17, 2026.

What is the market cap of Biote (BTMD)?

The market cap of Biote (BTMD) is approximately 42.5M.

BTMD Rankings

BTMD Stock Data

42.49M
27.96M
Medical Care Facilities
Medicinal Chemicals & Botanical Products
Link
United States
IRVING

BTMD RSS Feed